drospirenone and ethinyl estradiol combination has been researched along with norgestrel in 6 studies
| Studies (drospirenone and ethinyl estradiol combination) | Trials (drospirenone and ethinyl estradiol combination) | Recent Studies (post-2010) (drospirenone and ethinyl estradiol combination) | Studies (norgestrel) | Trials (norgestrel) | Recent Studies (post-2010) (norgestrel) |
|---|---|---|---|---|---|
| 130 | 51 | 102 | 2,311 | 492 | 104 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lynen, RF | 1 |
| Briones-Landa, CH; Bustillos-Alamilla, E; Hernández-Ruiz, MA; Zepeda-Zaragoza, J | 1 |
| Barbaud, A; Schmutz, JL; Trechot, P | 1 |
| Burke, AE; Espey, E; Raymond, EG | 1 |
| Cheetham, TC; Connell, FA; Cooper, WO; Davis, D; Graham, DJ; Ouellet-Hellstrom, R; Quesenberry, CP; Sidney, S; Sorel, M | 1 |
| Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P | 1 |
1 trial(s) available for drospirenone and ethinyl estradiol combination and norgestrel
| Article | Year |
|---|---|
[Combined hormonal contraception in cycles artificially extended].
Topics: Administration, Cutaneous; Adolescent; Adult; Androstenes; Breast Diseases; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Dysmenorrhea; Ethinyl Estradiol; Female; Headache; Humans; Menstrual Cycle; Norgestrel; Patient Acceptance of Health Care; Prospective Studies; Time Factors; Uterine Hemorrhage; Young Adult | 2010 |
5 other study(ies) available for drospirenone and ethinyl estradiol combination and norgestrel
| Article | Year |
|---|---|
Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial.
Topics: Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norgestrel; Reproductive Control Agents | 2010 |
[Systemic photosensibility and contraception].
Topics: Administration, Cutaneous; Administration, Oral; Adult; Androstenes; Contraceptive Agents, Female; Drug Combinations; Drug Eruptions; Ethinyl Estradiol; Female; Humans; Norgestrel; Photosensitivity Disorders | 2011 |
Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
Topics: Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Labeling; Ethinyl Estradiol; Female; Humans; Norgestrel; Risk Assessment; Venous Thromboembolism | 2012 |
Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
Topics: Adolescent; Adult; Androstenes; Arteries; California; Child; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hospitalization; Humans; Incidence; Middle Aged; Myocardial Infarction; Norgestrel; Proportional Hazards Models; Risk Factors; Stroke; Tennessee; Thromboembolism; Time Factors; Venous Thromboembolism; Washington; Young Adult | 2013 |
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult | 2013 |